Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
1.925
+0.065 (3.49%)
Nov 5, 2024, 1:14 PM EST - Market open
Immuneering Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 59.73 | 59.41 | 72.64 | 74.89 | 37.09 | 13.78 |
Short-Term Investments | - | 26.26 | 32.89 | 74.31 | - | - |
Cash & Short-Term Investments | 59.73 | 85.67 | 105.52 | 149.2 | 37.09 | 13.78 |
Cash Growth | -45.20% | -18.82% | -29.27% | 302.26% | 169.12% | - |
Receivables | - | - | 0.01 | 0.25 | 0.5 | 0.21 |
Prepaid Expenses | 3.96 | 3.42 | 3.21 | 2.89 | 0.14 | 0.07 |
Total Current Assets | 63.69 | 89.08 | 108.75 | 152.33 | 37.73 | 14.06 |
Property, Plant & Equipment | 5.12 | 5.4 | 5.78 | 6.13 | 0.68 | 0.04 |
Long-Term Investments | - | - | - | 1 | - | - |
Goodwill | 6.69 | 6.69 | 6.69 | 6.7 | - | - |
Other Intangible Assets | 0.37 | 0.38 | 0.41 | 0.44 | - | - |
Other Long-Term Assets | 1.23 | 1.03 | 0.74 | 0.1 | 0.01 | - |
Total Assets | 77.09 | 102.58 | 122.37 | 166.7 | 38.42 | 14.1 |
Accounts Payable | 2.62 | 2.11 | 3.15 | 1.39 | 1.48 | 0.29 |
Accrued Expenses | 3.76 | 5.17 | 4.5 | 3.97 | 0.7 | 0.21 |
Current Portion of Leases | 0.31 | 0.3 | 0.38 | 0.27 | 0.08 | - |
Other Current Liabilities | 0.09 | 0.26 | 0.02 | - | - | - |
Total Current Liabilities | 6.78 | 7.85 | 8.05 | 5.63 | 2.26 | 0.51 |
Long-Term Debt | - | - | - | - | - | 3.51 |
Long-Term Leases | 4 | 4.16 | 4.46 | 5.09 | 0.54 | - |
Total Liabilities | 10.78 | 12.01 | 12.52 | 10.72 | 2.8 | 4.02 |
Common Stock | 0.03 | 0.03 | 0.03 | 0.03 | 0 | 0 |
Additional Paid-In Capital | 257.92 | 253.81 | 219.64 | 215.28 | 3.25 | 2.17 |
Retained Earnings | -191.65 | -163.26 | -109.79 | -59.27 | -25.74 | -8.7 |
Comprehensive Income & Other | - | -0 | -0.03 | -0.05 | - | - |
Total Common Equity | 66.31 | 90.58 | 109.85 | 155.98 | -22.48 | -6.53 |
Shareholders' Equity | 66.31 | 90.58 | 109.85 | 155.98 | 35.62 | 10.08 |
Total Liabilities & Equity | 77.09 | 102.58 | 122.37 | 166.7 | 38.42 | 14.1 |
Total Debt | 4.31 | 4.46 | 4.84 | 5.36 | 0.62 | 3.51 |
Net Cash (Debt) | 55.42 | 81.2 | 100.68 | 144.83 | 36.47 | 10.27 |
Net Cash Growth | -46.89% | -19.35% | -30.48% | 297.13% | 255.02% | - |
Net Cash Per Share | 1.89 | 2.86 | 3.82 | 10.64 | 7.37 | 2.08 |
Filing Date Shares Outstanding | 29.65 | 29.28 | 26.44 | 26.38 | 4.95 | 4.95 |
Total Common Shares Outstanding | 29.65 | 29.27 | 26.42 | 26.32 | 4.95 | 4.95 |
Working Capital | 56.9 | 81.24 | 100.69 | 146.7 | 35.48 | 13.56 |
Book Value Per Share | 2.24 | 3.09 | 4.16 | 5.93 | -4.54 | -1.32 |
Tangible Book Value | 59.25 | 83.51 | 102.75 | 148.84 | -22.48 | -6.53 |
Tangible Book Value Per Share | 2.00 | 2.85 | 3.89 | 5.65 | -4.54 | -1.32 |
Machinery | 1.9 | 1.83 | 1.5 | 0.83 | 0.19 | 0.14 |
Leasehold Improvements | 0.3 | 0.3 | 0.29 | 0.15 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.